Planet 13 Holdings (PLNH) Total Current Liabilities (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Total Current Liabilities came in at $21.3 million in Q1 2026, down 15.63% year-on-year from $25.3 million in Q1 2025, and down 7.87% on a QoQ basis from $23.1 million in Q4 2025.

Planet 13 Holdings (PLNH) Total Current Liabilities (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Total Current Liabilities data on file, last reported at $21.3 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 15.63% year-over-year to $21.3 million in Q1 2026; TTM through Mar 2026 was $21.3 million, a 15.63% decrease from a year earlier, with the FY2025 full-year figure at $23.1 million, down 8.71% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $21.3 million, down from $23.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PLNH reached as high as $42.6 million in Q3 2024 and fell as low as $9.9 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $20.4 million across 5 years, with a median of $16.3 million in 2024.
  • Across the five-year window, Total Current Liabilities surged 219.3% in 2024 and sank 37.82% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $15.4 million in 2022, then decreased by 0.55% to $15.3 million in 2023, then jumped by 65.78% to $25.3 million in 2024, then decreased by 8.71% to $23.1 million in 2025, then retreated by 7.87% to $21.3 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $21.3 million in Q1 2026, $23.1 million in Q4 2025, and $26.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn 21.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.32 Mn
Dec 31, 2025 23.14 Mn
Sep 30, 2025 26.50 Mn
Jun 30, 2025 27.53 Mn
Mar 31, 2025 25.27 Mn
Dec 31, 2024 25.35 Mn
Sep 30, 2024 42.62 Mn
Jun 30, 2024 34.75 Mn
Mar 31, 2024 16.30 Mn
Dec 31, 2023 15.29 Mn
Sep 30, 2023 13.35 Mn
Jun 30, 2023 12.22 Mn
Mar 31, 2023 12.68 Mn
Dec 31, 2022 15.37 Mn
Sep 30, 2022 10.50 Mn
Jun 30, 2022 9.93 Mn
Mar 31, 2022 14.15 Mn
Dec 31, 2021 12.73 Mn